Volker Schellenberger

 Volker  Schellenberger
Volker Schellenberger
President and CEO

Presentations at Drug Discovery 2015

Thu3  Sep03:00pm(30 mins)
XTEN Protein Polymer for Half-Life Extension and Tumor Drug Delivery

Session: New Biological Drugs & Technologies
Room: To be announced

Profile of Volker Schellenberger

Volker Schellenberger is President and CEO of Amunix Operating Inc, which he co-founded with Willem Pim Stemmer in 2006. He initially served as Amunix’ Chief Scientific Officer and is the lead inventor of the company’s XTEN technology. XTEN enables the engineering of biotherapeutics with long in-vivo half-life and low safety risk due to their biodegradable nature. XTENylated pharmaceuticals can be efficiently produced by recombinant expression as well as by bioconjugation. The favorable properties of XTEN have been confirmed in multiple clinical trials.
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018